Smith-Swintosky; Virginia L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Smith-Swintosky; Virginia L..The latest application filed is for "use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine".

Company Profile

0.18.28

Smith-Swintosky; Virginia L. - Hatfield PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder Grant 8,937,096 - Smith-Swintosky , et al. January 20, 2	2015-01-20
Co-therapy for the treatment of epilepsy and related disorders Grant 8,853,263 - Smith-Swintosky , et al. October 7, 2	2014-10-07
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain Grant 8,716,231 - Smith-Swintosky , et al. May 6, 2	2014-05-06
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction Grant 8,691,867 - Smith-Swintosky , et al. April 8, 2	2014-04-08
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators Grant 8,501,791 - Eisinger , et al. August 6, 2	2013-08-06
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels Grant 8,497,298 - Smith-Swintosky , et al. July 30, 2	2013-07-30
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity Grant 8,492,431 - Smith-Swintosky , et al. July 23, 2	2013-07-23
Use Of Benzo-fused Heterocyle Sulfamide Derivatives For The Treatment Of Migraine App 20120065257 - Smith-Swintosky; Virginia L.	2012-03-15
0novel, 1,2,4-thiadiazolium Derivatives As Melanocortin Receptor Modulators App 20100280079 - Eisinger; Magdalena ; et al.	2010-11-04
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators Grant 7,786,311 - Eisinger , et al. August 31, 2	2010-08-31
Use Of Benzo-fused Heterocyle Sulfamide Derivatives For The Treatment Of Anxiety App 20090247616 - Smith-Swintosky; Virginia L.	2009-10-01
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For Disease Modification / Epileptogenesis App 20090209634 - Smith-Swintosky; Virginia L.	2009-08-20
Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators App 20090203751 - Eisinger; Magdalena Eisinger ; et al.	2009-08-13
1,2,4-thiadiazole derivatives as melanocortin receptor modulators Grant 7,375,123 - Eisinger , et al. May 20, 2	2008-05-20
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For The Treatment Of Obesity App 20080027131 - Smith-Swintosky; Virginia L. ; et al.	2008-01-31
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators Grant 7,319,107 - Eisinger , et al. January 15, 2	2008-01-15
Co-therapy For The Treatment Of Epilepsy And Related Disorders App 20070293440 - Smith-Swintosky; Virginia L. ; et al.	2007-12-20
Co-therapy For The Treatment Of Epilepsy And Related Disorders App 20070293476 - Smith-Swintosky; Virginia L. ; et al.	2007-12-20
Use Of Benzo-heteroaryl Sulfamide Derivatives As Neuroprotective Agents App 20070191451 - Smith-Swintosky; Virginia L.	2007-08-16
Use Of Benzo-heteroaryl Sulfamide Derivatives For The Treatment Of Substance Abuse And Addiction App 20070191453 - Smith-Swintosky; Virginia L.	2007-08-16
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis App 20070191460 - Smith-Swintosky; Virginia L.	2007-08-16
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder App 20070191450 - Smith-Swintosky; Virginia L.	2007-08-16
Use Of Benzo-heteroaryl Sulfamide Derivatives For The Treatment Of Migraine App 20070191461 - Smith-Swintosky; Virginia L.	2007-08-16
Use Of Benzo-fused Heterocyle Sulfamide Derivatives For The Treatment Of Migraine App 20070191474 - Smith-Swintosky; Virginia L.	2007-08-16
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression App 20070191449 - Smith-Swintosky; Virginia L.	2007-08-16
Use Of Benzo-heteroaryl Sulfamide Derivatives For The Treatment Of Pain App 20070191452 - Smith-Swintosky; Virginia L.	2007-08-16
Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels App 20070191459 - Smith-Swintosky; Virginia L.	2007-08-16
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For The Treatment Of Depression App 20070155827 - Smith-Swintosky; Virginia L. ; et al.	2007-07-05
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For Disease Modification / Epileptogenesis App 20070155824 - Smith-Swintosky; Virginia L.	2007-07-05
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For The Treatment Of Pain App 20070155822 - Smith-Swintosky; Virginia L. ; et al.	2007-07-05
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For The Treatment Of Substance Abuse And Addiction App 20070155825 - Smith-Swintosky; Virginia L. ; et al.	2007-07-05
Use Of Benzo-fused Heterocycle Sulfamide Derivatives As Neuroprotective Agents App 20070155823 - Smith-Swintosky; Virginia L. ; et al.	2007-07-05
Use Of Benzo-fused Heterocyle Sulfamide Derivatives For The Treatment Of Mania And Bipolar Disorder App 20070155826 - Smith-Swintosky; Virginia L. ; et al.	2007-07-05
Use Of Benzo-fused Heterocycle Sulfamide Derivatives For Lowering Lipids And Lowering Blood Glucose Levels App 20070155821 - Smith-Swintosky; Virginia L. ; et al.	2007-07-05
Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators App 20060128772 - Eisinger; Magdalena ; et al.	2006-06-15
1,2,4-thiadiazole derivatives as melanocortin receptor modulators Grant 7,049,331 - Eisinger , et al. May 23, 2	2006-05-23
Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators App 20060030604 - Elsinger; Magdalena ; et al.	2006-02-09
Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators App 20030176425 - Eisinger, Magdalena ; et al.	2003-09-18
Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators App 20030162819 - Eisinger, Magdalena ; et al.	2003-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.